Mylan announced that it has received final approval from the FDA for its Abbreviated New Drug Application (ANDA) for Levalbuterol Inhalation Solution, the generic version of Sunovion’s Xopenex ...

March 17, 2005 — The U.S. Food and Drug Administration (FDA) has approved a new indication for temozolomide, allowing its use in the first-line treatment of glioblastoma multiforme; orphan drug status ...

Levalbuterol (as tartrate) (single-isomer albuterol) 45mcg/inh; metered dose inhaler; CFC-free. The pharmacological effects of beta 2-adrenoceptor agonist drugs are at least in part attributable to ...

The U.S. Food and Drug Administration recently issued a public health advisory to alert patients, caregivers and health care professionals to switch to hydrofluoroalkane or HFA-propelled albuterol ...

MARLBOROUGH, Mass. -- Sepracor Inc.'s asthma drug Xopenex was approved by the Food and Drug Administration for use in inhalers, adding an environmentally friendly drug to the market and providing a ...

Sunovion Pharmaceuticals Inc. to Divest Xopenex® (levalbuterol HCI) Inhalation Solution (IS) to Akorn, Inc. MARLBOROUGH, Mass., Sep 30, 2014 (BUSINESS WIRE) -- Sunovion Pharmaceuticals Inc. (Sunovion) ...

Last warning: Asthma inhalers go "green" on Dec. 31, forcing patients still using the old-fashioned kind to make a pricey and even confusing switch. The medicine inside these rescue inhalers — the ...

WASHINGTON The Food and Drug Administration today issued a public health advisory to alert patients, caregivers and healthcare professionals to switch to hydrofluoroalkane propelled albuterol inhalers ...

Co confirms that its subsidiary, Barr Laboratories, Inc., has initiated a challenge of the patents listed by Sepracor Inc. in connection with its Xopenex 0.31mg/3mL, 0.63mg/3mL and 1.25mg/3mL. On July ...

Last warning: Asthma inhalers go "green" on Dec. 31, forcing patients still using the old-fashioned kind to make a pricey and even confusing switch. The medicine inside these rescue inhalers — the ...